Caricamento...
Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2–5 Years in the United States
In a phase 4, randomized, placebo-controlled, double-blind, multicenter study, to assess the safety and immunogenicity of live, attenuated cholera vaccine PXVX0200 in children aged 2–5 years in the United States, 172 volunteers were randomized 6:1 to receive a single dose of 1 × 10(9) colony forming...
Salvato in:
| Pubblicato in: | Am J Trop Med Hyg |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
The American Society of Tropical Medicine and Hygiene
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941807/ https://ncbi.nlm.nih.gov/pubmed/33319739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.20-0917 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|